Will methylation assays be part of a full molecular strategy to improve clinical management of cervical neoplasia?
作者信息
El-Zein Mariam, Franco Eduardo L
机构信息
Division of Cancer Epidemiology, McGill University, Montréal, QC, H4A 3T2, Canada.
出版信息
Epigenomics. 2024;16(18):1197-1201. doi: 10.1080/17501911.2024.2402684. Epub 2024 Sep 25.
Abstract
摘要
相似文献
1
Will methylation assays be part of a full molecular strategy to improve clinical management of cervical neoplasia?甲基化检测会成为改善宫颈肿瘤临床管理的完整分子策略的一部分吗？
Epigenomics. 2024;16(18):1197-1201. doi: 10.1080/17501911.2024.2402684. Epub 2024 Sep 25.
2
Clinical indications for host-cell DNA methylation markers in cervical screening and management of cervical intraepithelial neoplasia: A review.宿主细胞DNA甲基化标志物在宫颈筛查及宫颈上皮内瘤变管理中的临床应用：综述
Tumour Virus Res. 2024 Dec 16;19:200308. doi: 10.1016/j.tvr.2024.200308.
3
The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions.宿主和/或人乳头瘤病毒（HPV）DNA 甲基化在管理 2 级宫颈上皮内瘤变（CIN2）病变中的作用。
Int J Mol Sci. 2023 Mar 30;24(7):6479. doi: 10.3390/ijms24076479.
4
The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review.利用宿主细胞 DNA 甲基化分析检测和管理高级别宫颈上皮内瘤变女性：综述。
BJOG. 2021 Feb;128(3):504-514. doi: 10.1111/1471-0528.16395. Epub 2020 Aug 9.
5
Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.甲基化估计了细胞学和 HPV16/18 基因分型结果不一致的 HPV 感染女性的癌前病变风险。
Clin Epigenetics. 2019 Oct 12;11(1):140. doi: 10.1186/s13148-019-0743-9.
6
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review.人乳头瘤病毒检测在初级宫颈筛查及杂交捕获 2 检测截断值：系统评价。
BMJ. 2011 May 23;342:d2757. doi: 10.1136/bmj.d2757.
7
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.甲基化标志物在宫颈癌早期检测中的应用：科学现状评估
Gynecol Oncol. 2009 Feb;112(2):293-9. doi: 10.1016/j.ygyno.2008.10.012. Epub 2008 Dec 2.
8
Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.HPV 16 基因甲基化联合 E6 癌蛋白在宫颈癌筛查中的风险分层：一项 10 年前瞻性队列研究。
Clin Epigenetics. 2020 May 7;12(1):62. doi: 10.1186/s13148-020-00853-1.
9
Epigenome-wide differential methylation and differential variability as predictors of high-grade cervical intraepithelial neoplasia (CIN2+).全基因组表观遗传差异甲基化和差异变异性作为高级别宫颈上皮内瘤变（CIN2+）的预测指标。
Am J Epidemiol. 2025 Apr 8;194(4):1012-1022. doi: 10.1093/aje/kwae254.
10
Evaluation of / methylation as a triage test for cervical intraepithelial neoplasia and cervical cancer.评价 / 甲基化作为宫颈上皮内瘤变和宫颈癌的分诊试验。
Epigenomics. 2023 Feb;15(3):131-145. doi: 10.2217/epi-2022-0396. Epub 2023 Apr 5.
本文引用的文献
1
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.在中低收入国家，用于检测高危恶性进展的宫颈病变的高性能甲基化 DNA 标志物的发现和技术验证。
Clin Epigenetics. 2024 Apr 20;16(1):56. doi: 10.1186/s13148-024-01669-z.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据：全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
DNA methylation as a triage tool for cervical cancer screening - A meeting report.DNA甲基化作为宫颈癌筛查的一种分类工具——会议报告
Prev Med Rep. 2024 Mar 6;41:102678. doi: 10.1016/j.pmedr.2024.102678. eCollection 2024 May.
4
Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process.持久共识指南：宫颈癌筛查和管理——范围和流程介绍。
J Low Genit Tract Dis. 2024 Apr 1;28(2):117-123. doi: 10.1097/LGT.0000000000000804. Epub 2024 Mar 2.
5
Comparing the Costs and Diagnostic Outcomes of Replacing Cytology with the QIAsure DNA Methylation Test as a Triage within HPV Primary Cervical Cancer Screening in The Netherlands.在荷兰人乳头瘤病毒（HPV）原发性宫颈癌筛查中，比较用QIAsure DNA甲基化检测替代细胞学检查作为分流手段的成本和诊断结果。
Diagnostics (Basel). 2023 Dec 6;13(24):3612. doi: 10.3390/diagnostics13243612.
6
Validation of novel DNA methylation markers in cervical precancer and cancer.新型DNA甲基化标志物在子宫颈癌前病变和癌症中的验证
Int J Cancer. 2024 Jan 1;154(1):104-113. doi: 10.1002/ijc.34686. Epub 2023 Aug 22.
7
DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis.基于 HPV 的宫颈癌筛查中 DNA 甲基化作为阴道镜转诊的分流标志物：系统评价和荟萃分析。
Clin Epigenetics. 2023 Aug 2;15(1):125. doi: 10.1186/s13148-023-01537-2.
8
2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia.2023 年加拿大阴道镜检查指南：基于风险的宫颈上皮内瘤样病变管理和监测方法。
Curr Oncol. 2023 Jun 13;30(6):5738-5768. doi: 10.3390/curroncol30060431.
9
Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?规划、实施和维持高覆盖率的人乳头瘤病毒（HPV）疫苗接种计划：在资源有限的国家背景下，哪些措施有效？
Front Public Health. 2023 Apr 14;11:1112981. doi: 10.3389/fpubh.2023.1112981. eCollection 2023.
10
Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of DNA Methylation (CONCERVE Study).高级别宫颈上皮内瘤变的临床消退与 DNA 甲基化缺失相关（CONCERVE 研究）。
J Clin Oncol. 2022 Sep 10;40(26):3037-3046. doi: 10.1200/JCO.21.02433. Epub 2022 May 5.
Zotero 插件